Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer

MLA

Neal Patel, et al. “Transcriptomic Recurrence Score Improves Recurrence Prediction for Surgically Treated Patients with Intermediate‐risk Clear Cell Kidney Cancer.” Cancer Medicine, vol. 12, no. 5, Mar. 2023, pp. 6437–44. EBSCOhost, https://doi.org/10.1002/cam4.5399.

APA

Neal Patel, Alexander Hakansson, Shinji Ohtake, Peter Muraki, James A. Proudfout, Yang Liu, Lisa Webber, Arkaitz Ibarra, Vinnie Y. T. Liu, Elai Davicioni, Karim Chamie, Allan Pantuck, & Brian Shuch. (2023). Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer. Cancer Medicine, 12(5), 6437–6444. https://doi.org/10.1002/cam4.5399

Chicago

Neal Patel, Alexander Hakansson, Shinji Ohtake, Peter Muraki, James A. Proudfout, Yang Liu, Lisa Webber, et al. 2023. “Transcriptomic Recurrence Score Improves Recurrence Prediction for Surgically Treated Patients with Intermediate‐risk Clear Cell Kidney Cancer.” Cancer Medicine 12 (5): 6437–44. doi:10.1002/cam4.5399.